Ajah, A.A.; Lembede, B.W.; Nkomozepi, P.; Erlwanger, K.H.; Nyakudya, T.T.
Neonatal Oral Administration of Chrysin Prevents Long-Term Development of Non-Alcoholic Fatty Liver Disease in a Sexually Dimorphic Manner in Fructose Nurtured Sprague Dawley Rats. Life 2022, 12, 790.
https://doi.org/10.3390/life12060790
AMA Style
Ajah AA, Lembede BW, Nkomozepi P, Erlwanger KH, Nyakudya TT.
Neonatal Oral Administration of Chrysin Prevents Long-Term Development of Non-Alcoholic Fatty Liver Disease in a Sexually Dimorphic Manner in Fructose Nurtured Sprague Dawley Rats. Life. 2022; 12(6):790.
https://doi.org/10.3390/life12060790
Chicago/Turabian Style
Ajah, Austin A., Busisani W. Lembede, Pilani Nkomozepi, Kennedy H. Erlwanger, and Trevor T. Nyakudya.
2022. "Neonatal Oral Administration of Chrysin Prevents Long-Term Development of Non-Alcoholic Fatty Liver Disease in a Sexually Dimorphic Manner in Fructose Nurtured Sprague Dawley Rats" Life 12, no. 6: 790.
https://doi.org/10.3390/life12060790
APA Style
Ajah, A. A., Lembede, B. W., Nkomozepi, P., Erlwanger, K. H., & Nyakudya, T. T.
(2022). Neonatal Oral Administration of Chrysin Prevents Long-Term Development of Non-Alcoholic Fatty Liver Disease in a Sexually Dimorphic Manner in Fructose Nurtured Sprague Dawley Rats. Life, 12(6), 790.
https://doi.org/10.3390/life12060790
